<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02725671</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00033908</org_study_id>
    <nct_id>NCT02725671</nct_id>
  </id_info>
  <brief_title>Cardiogoniometry for Detecting Coronary Artery Disease by CT Angiography</brief_title>
  <official_title>Cardiogoniometry for Detecting Coronary Artery Disease by CT Angiography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Enverdis Corp.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiogoniometry is a technique to process and evaluate vectorcardiography from regular ECG
      acquisitions. Vectorcardiography has a long tradition in cardiology for providing
      comprehensive information on myocardial function and integrity. In recent years, computer
      assisted analysis has allowed automated interpretation of vectorcardiography with promising
      results in comparison to standard ECG for identifying patients with coronary heart disease.
      This study aims to investigate the utility of cardiogoniometry for noninvasively identifying
      patients who are at risk from coronary heart disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiogoniometry is a technique to process and evaluate vectorcardiography from regular ECG
      acquisitions. Vectorcardiography has a long tradition in cardiology for providing
      comprehensive information on myocardial function and integrity. Compared to standard
      electrocardiography, vectorcardiography has shown to be more sensitive to detect structural
      and ischemic heart disease. Unfortunately, the interpretation of vectorcardiography is
      complex which has hindered its widespread application. In recent years, computer assisted
      analysis has allowed automated interpretation of vectorcardiography with promising results in
      comparison to standard ECG for identifying patients with ischemic heart disease. However, the
      underlying mechanisms and threshold of altered cardiac vectors in the presence of coronary
      artery disease are not well understood. This research aims at exploring the relationship of
      computer assisted analysis of vectorcardiography with the presence, extent, severity, and
      location of coronary artery disease in comparison to standard ECG evaluation. Furthermore,
      the investigators intent to follow up enrolled patients for the occurrence of adverse
      cardiovascular events for correlation with test findings. These data will provide
      comprehensive information on the diagnostic performance of noninvasive, inexpensive
      evaluation of cardiac vector loops for identifying patients at risk from coronary artery
      disease. Specifically, the study aims to:

        1. Compare the diagnostic accuracy of cardiogoniometry with standard ECG for detecting
           coronary artery disease as assessed by CT angiography

        2. Investigate the relationship between abnormal cardiogoniometry findings and the
           extent/severity/location of coronary artery disease by CT angiography

        3. Compare the intermediate term prognosis of patients according to cardiogoniometry,
           standard ECG, and CT findings
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Poor enrollment due to insufficient study support.
  </why_stopped>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">June 26, 2020</completion_date>
  <primary_completion_date type="Actual">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of Identifying Patients With at Least One 50 Percent or Greater Coronary Artery Stenosis by CT Angiography</measure>
    <time_frame>30 days from CGM analysis</time_frame>
    <description>Area under curve (AUC) analysis is proposed to be used to determine the diagnostic accuracy of cardiogoniometry for detecting patients with coronary heart disease as defined by at least one 50% or greater stenosis on CT coronary angiography.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Accuracy of Identifying Patients With Any Coronary Atherosclerotic Disease by CT Angiography</measure>
    <time_frame>30 days</time_frame>
    <description>Area under the curve (AUC) analysis is proposed to be used to asses the diagnostic accuracy of CGM for identifying patients with any coronary atherosclerotic disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Death at Follow up</measure>
    <time_frame>5 years after enrollment</time_frame>
    <description>Patient follow up data will be used to performance of CGM to identify patients who are at risk of suffering adverse cardiac events at follow up compared to coronary CT angiography using AUC analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk of Myocardial Infarction</measure>
    <time_frame>5 years after enrollment</time_frame>
    <description>Incidence of myocardial infarction at follow up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk of Revascularization at Follow up</measure>
    <time_frame>5 year after enrollment</time_frame>
    <description>Incidence of revascularization at follow up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk of Hospitalization</measure>
    <time_frame>5 years after enrollment</time_frame>
    <description>Incidence of hospitalization at follow up</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Coronary Heart Disease</condition>
  <condition>Coronary Artery Disease</condition>
  <condition>Ischemic Heart Disease</condition>
  <arm_group>
    <arm_group_label>Cardiogoniometry and ECG Assessment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The same patient will undergo both advanced ECG assessment using cardiogoniometry and standard ECG</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Explorer</intervention_name>
    <description>ECG device which records comprehensive voltage potential data in the myocardium</description>
    <arm_group_label>Cardiogoniometry and ECG Assessment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients age 18 or older who are referred for elective cardiac CT examination for
             evaluation of coronary artery disease

        Exclusion Criteria:

          -  hemodynamic instability

          -  history of anaphylactic contrast reaction

          -  inability of following breath hold instructions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Armin A Zadeh, MD PhD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>March 10, 2016</study_first_submitted>
  <study_first_submitted_qc>March 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2016</study_first_posted>
  <results_first_submitted>January 10, 2020</results_first_submitted>
  <results_first_submitted_qc>February 7, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 25, 2020</results_first_posted>
  <last_update_submitted>June 26, 2020</last_update_submitted>
  <last_update_submitted_qc>June 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 3, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/71/NCT02725671/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Study Group</title>
          <description>Single study group. All patients are planned to undergo both tests, Cardiogoniometry (CGM) and CT angiography.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Study Group</title>
          <description>Single study group. All patients are planned to undergo both tests, CGM and CT angiography.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56" lower_limit="44" upper_limit="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cardiac Risk Factors</title>
          <description>Number of patients with traditional risk factors, i.e., Hypertension, Diabetes Mellitus, Hyperlipidemia, smoking will be recorded.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Accuracy of Identifying Patients With at Least One 50 Percent or Greater Coronary Artery Stenosis by CT Angiography</title>
        <description>Area under curve (AUC) analysis is proposed to be used to determine the diagnostic accuracy of cardiogoniometry for detecting patients with coronary heart disease as defined by at least one 50% or greater stenosis on CT coronary angiography.</description>
        <time_frame>30 days from CGM analysis</time_frame>
        <population>Minimum data needed for this measure was not collected and therefore could not be calculated.</population>
        <group_list>
          <group group_id="O1">
            <title>Study Group</title>
            <description>Single study group. All patients are planned to undergo both tests, CGM and CT angiography.</description>
          </group>
        </group_list>
        <measure>
          <title>Accuracy of Identifying Patients With at Least One 50 Percent or Greater Coronary Artery Stenosis by CT Angiography</title>
          <description>Area under curve (AUC) analysis is proposed to be used to determine the diagnostic accuracy of cardiogoniometry for detecting patients with coronary heart disease as defined by at least one 50% or greater stenosis on CT coronary angiography.</description>
          <population>Minimum data needed for this measure was not collected and therefore could not be calculated.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Accuracy of Identifying Patients With Any Coronary Atherosclerotic Disease by CT Angiography</title>
        <description>Area under the curve (AUC) analysis is proposed to be used to asses the diagnostic accuracy of CGM for identifying patients with any coronary atherosclerotic disease</description>
        <time_frame>30 days</time_frame>
        <population>Insufficient enrollment for analysis for this outcome measure</population>
        <group_list>
          <group group_id="O1">
            <title>Study Group</title>
            <description>Single study group. All patients are planned to undergo both tests, Cardiogoniometry (CGM) and CT angiography.</description>
          </group>
        </group_list>
        <measure>
          <title>Accuracy of Identifying Patients With Any Coronary Atherosclerotic Disease by CT Angiography</title>
          <description>Area under the curve (AUC) analysis is proposed to be used to asses the diagnostic accuracy of CGM for identifying patients with any coronary atherosclerotic disease</description>
          <population>Insufficient enrollment for analysis for this outcome measure</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Death at Follow up</title>
        <description>Patient follow up data will be used to performance of CGM to identify patients who are at risk of suffering adverse cardiac events at follow up compared to coronary CT angiography using AUC analysis.</description>
        <time_frame>5 years after enrollment</time_frame>
        <population>Insufficient enrollment for analysis of this outcome measure</population>
        <group_list>
          <group group_id="O1">
            <title>Study Group</title>
            <description>Single study group. All patients are planned to undergo both tests, Cardiogoniometry (CGM) and CT angiography.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Death at Follow up</title>
          <description>Patient follow up data will be used to performance of CGM to identify patients who are at risk of suffering adverse cardiac events at follow up compared to coronary CT angiography using AUC analysis.</description>
          <population>Insufficient enrollment for analysis of this outcome measure</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Risk of Myocardial Infarction</title>
        <description>Incidence of myocardial infarction at follow up</description>
        <time_frame>5 years after enrollment</time_frame>
        <population>Insufficient enrollment for analysis of this outcome measure</population>
        <group_list>
          <group group_id="O1">
            <title>Cardiogoniometry and ECG Assessment</title>
            <description>The same patient will undergo both advanced ECG assessment using cardiogoniometry and standard ECG
Explorer: ECG device which records comprehensive voltage potential data in the myocardium</description>
          </group>
        </group_list>
        <measure>
          <title>Risk of Myocardial Infarction</title>
          <description>Incidence of myocardial infarction at follow up</description>
          <population>Insufficient enrollment for analysis of this outcome measure</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Risk of Revascularization at Follow up</title>
        <description>Incidence of revascularization at follow up</description>
        <time_frame>5 year after enrollment</time_frame>
        <population>Insufficient enrollment for analysis of this outcome measure</population>
        <group_list>
          <group group_id="O1">
            <title>Cardiogoniometry and ECG Assessment</title>
            <description>The same patient will undergo both advanced ECG assessment using cardiogoniometry and standard ECG
Explorer: ECG device which records comprehensive voltage potential data in the myocardium</description>
          </group>
        </group_list>
        <measure>
          <title>Risk of Revascularization at Follow up</title>
          <description>Incidence of revascularization at follow up</description>
          <population>Insufficient enrollment for analysis of this outcome measure</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Risk of Hospitalization</title>
        <description>Incidence of hospitalization at follow up</description>
        <time_frame>5 years after enrollment</time_frame>
        <population>Insufficient enrollment for analysis of this outcome measure</population>
        <group_list>
          <group group_id="O1">
            <title>Cardiogoniometry and ECG Assessment</title>
            <description>The same patient will undergo both advanced ECG assessment using cardiogoniometry and standard ECG
Explorer: ECG device which records comprehensive voltage potential data in the myocardium</description>
          </group>
        </group_list>
        <measure>
          <title>Risk of Hospitalization</title>
          <description>Incidence of hospitalization at follow up</description>
          <population>Insufficient enrollment for analysis of this outcome measure</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>4 years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Cardiogoniometry and ECG Assessment</title>
          <description>The same patient will undergo both advanced ECG assessment using cardiogoniometry and standard ECG
Explorer: ECG device which records comprehensive voltage potential data in the myocardium</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Armin Zadeh</name_or_title>
      <organization>Johns Hopkins University</organization>
      <phone>4105020549</phone>
      <email>arminzadeh@jhu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

